The aims of this study were to assess the prognostic value of PD-L1 and phosphorylated ERK (p-ERK) expression in TCL and to investigate whether PD-1/PD-L1 binding could directly activate the intracellular ERK1/2 pathway in tumor cells. This evidence concerns the gene PDCD1 and neoplasm.